1.
What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population
2.
3.
The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis
Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians
Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study
Financial based agreements and performance based agreements: the Belgian experience